Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2000
05/04/2000WO1998019513A3 Method for the preparation of citalopram
05/04/2000DE19954040A1 Use of phenol derivatives, e.g. thymol, as prostaglandin antagonists and antiproliferative agents for treating tumors
05/04/2000DE19850131A1 Chromenon- und Chromanonderivate Chromenon- and chromanone
05/04/2000DE19849737A1 Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen Combining means for treating inflammatory bowel disease
05/04/2000DE19849722A1 Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted phenyl alkenoylguanidine, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/04/2000DE19849650A1 Use of N-(2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl)-acetamide derivatives as kappa receptor binders for treating and preventing irritable bowel syndrome
05/04/2000DE19849643A1 An das AAV-Kapsid bindender, den Zelltropismus verändernder Antikörper und Verfahren zum gerichteten Gentransfer At the AAV capsid binding, cell tropism changing antibodies and methods for directed gene transfer
05/04/2000CA2349523A1 Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348844A1 Compounds and their therapeutic use with diabetic complications
05/04/2000CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
05/04/2000CA2348563A1 Compositions and methods for treating polycystic kidney disease
05/04/2000CA2348529A1 Conductance of improperly folded proteins through the secretory pathway
05/04/2000CA2348452A1 Microparticles containing peg and/or peg glyceryl esters
05/04/2000CA2348430A1 Ovary-specific genes and proteins
05/04/2000CA2348281A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/04/2000CA2348165A1 Dihydropyridine compounds and methods of use
05/04/2000CA2348160A1 Use of antifungal agents for treating scleroses
05/04/2000CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
05/04/2000CA2348019A1 Method and composition for modulating amyloidosis
05/04/2000CA2347982A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
05/04/2000CA2347967A1 Substance for reduction of cholesterol as well as lipids content
05/04/2000CA2347911A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000CA2347828A1 Methods for enhancing wound healing
05/04/2000CA2347803A1 Microbial transformation product
05/04/2000CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000CA2347109A1 Fluticasone lotion having improved vasoconstrictor activity
05/04/2000CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000CA2347032A1 O/w emulsion comprising an hydroxylated oil
05/04/2000CA2346990A1 Serine protease inhibitor
05/04/2000CA2346873A1 Antitumor chrysene derivatives
05/04/2000CA2346820A1 Preparation and use of solidified oils
05/04/2000CA2344637A1 .delta.9 tetrahydrocannabinol (.delta.9 thc) solution metered dose inhalers and methods of use
05/04/2000CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000CA2342626A1 Substituted phenyl derivatives, their preparation and use
05/03/2000EP0997477A2 MHC complexes and uses thereof
05/03/2000EP0997474A1 Antithrombotic agents
05/03/2000EP0997473A1 Natural antitumor or antiviral substances and use of the same
05/03/2000EP0997466A1 Novel antimicrobial lactam-quinolones
05/03/2000EP0997465A1 Azaindole derivatives and their use as antithrombotic agents
05/03/2000EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
05/03/2000EP0997460A1 Benzothiophene compounds as antithrombotic agents and intermediates
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0997457A1 3-benzoylindole derivatives and drugs containing the same
05/03/2000EP0997153A1 Formulations for lipophilic compounds
05/03/2000EP0997146A1 A drug for treating diabetic nephrosis and delaying renal failure
05/03/2000EP0997145A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
05/03/2000EP0997137A1 Use of piperonal as an anti-inflammatory additive to cosmetics and medicaments
05/03/2000EP0997133A1 Use of 2-tert-butylhydroquinone for stabilizing of flavones, flavanones or flavonoids, and synergistic mixtures, cosmetic and dermatological preparations containing them
05/03/2000EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human
05/03/2000EP0996732A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
05/03/2000EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
05/03/2000EP0996725A1 Human nk-3 related prostate specific gene-1
05/03/2000EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof
05/03/2000EP0996626A1 Glycine transporter
05/03/2000EP0996623A1 2,6-DI-t-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY]PHENOL AND 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY]PHENOL
05/03/2000EP0996622A1 Novel spiroazabicyclic heterocyclic compounds
05/03/2000EP0996621A1 Novel compounds
05/03/2000EP0996620A1 Novel compounds
05/03/2000EP0996619A1 Tropane analogs and methods for inhibition of monoamine transport
05/03/2000EP0996618A1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
05/03/2000EP0996617A1 Novel compounds
05/03/2000EP0996614A1 Acrylonitrile compounds, process for their production and pesticides containing them
05/03/2000EP0996613A1 Tramadol, salts thereof and process for their preparation
05/03/2000EP0996612A2 Aliphatic propargylamines as cellular rescue agents
05/03/2000EP0996466A2 Novel composition comprising an ssri and a beta-blocker
05/03/2000EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6
05/03/2000EP0996454A1 Polyallylamine polymers for treating hypercholesterolemia
05/03/2000EP0996451A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
05/03/2000EP0996450A2 Method for the treatment of cancer with exochelins of mycobacterium tuberculosis
05/03/2000EP0996448A1 Treatment and prevention of adhesions
05/03/2000EP0996447A1 Combination therapy for modulating the human sexual response
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0996445A1 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri)
05/03/2000EP0996444A1 Treatment of diabetes with thiazolidinedione and metformin
05/03/2000EP0996443A1 Certain diarylimidazole derivatives; a new class of npy specific ligands
05/03/2000EP0996442A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
05/03/2000EP0996441A1 Pharmaceutical compositions of arglabin and arglabin derivatives
05/03/2000EP0996440A1 Method for treatment of glutamate related disorders
05/03/2000EP0996439A1 $g(b)-ALKOXYACRYLATES AGAINST MALARIA
05/03/2000EP0996438A1 Use of cis-6-hexadecenoic acid for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin
05/03/2000EP0996437A1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol
05/03/2000EP0996436A1 Pharmaceutical formulations containing poorly soluble drug substances
05/03/2000EP0996435A1 Amino acid derivatives useful to treat stroke
05/03/2000EP0996434A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
05/03/2000EP0996433A1 Methods for treatment of conditions associated with lactosylceramide
05/03/2000EP0996432A2 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
05/03/2000EP0996431A1 Synergistic compositions of lycopene and vitamin e for the prevention of ldl oxidation
05/03/2000EP0996430A2 Nucleotide analog compositions
05/03/2000EP0996429A1 Solid state solutions and dispersions of poorly water soluble drugs
05/03/2000EP0996428A2 Topical application of a combination of benzoyl peroxide and a second active ingredient
05/03/2000EP0996424A1 Solid pharmaceutical preparation
05/03/2000EP0996418A1 Dermatological compositions
05/03/2000EP0996410A1 Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
05/03/2000EP0862419B1 Microencapsulated dna for vaccination and gene therapy
05/03/2000EP0824354A4 Methods to inhibit late radiation-induced skin damage
05/03/2000EP0793657B1 Microbicidal triazolyl derivatives
05/03/2000EP0788474B1 Nitro-benzamides useful as anti-arrhythmic agents
05/03/2000EP0785924B1 Bis-2-aminopyridines, preparation method therefor and use thereof for controlling parasitic infections
1 ... 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 6337 6338 6339 6340 6341 6342 6343 6344 ... 7860